Biomarker-driven early lung cancer therapy: the future is now?

Editorial

Open access

Servet Bölükbas and Michael Eberlein

European journal of cardio-thoracic surgery, Vol.50(4), pp.764-765

10/2016

DOI: 10.1093/ejcts/ezw121

PMID: 27126131

Files and links (1)

url

https://doi.org/10.1093/ejcts/ezw121View

Published (Version of record) Open Access

Adenocarcinoma

Secondary Prevention

Prognosis

Biomarkers, Tumor

Lung Neoplasms

Humans

Title: Subtitle: Biomarker-driven early lung cancer therapy: the future is now?
Creators: Servet Bölükbas - Department of Thoracic Surgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany servet.boeluekbas@helios-kliniken.de
Michael Eberlein - Division of Pulmonary, Critical Care and Occupational Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA
Resource Type: Editorial
Publication Details: European journal of cardio-thoracic surgery, Vol.50(4), pp.764-765
DOI: 10.1093/ejcts/ezw121
PMID: 27126131
ISSN: 1010-7940
eISSN: 1873-734X
Language: English
Date published: 10/2016
Academic Unit: Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
Record Identifier: 9984094515102771

27 Record Views